23.4 C
New York
Thursday, June 11, 2026

Tag: progress

ASHEBORO, N.C., June 11, 2026 /PRNewswire/ -- Technimark, a global leader in plastic injection molding for healthcare, consumer packaging, and industrial markets, today announced...

Cosmos Health Secures Additional 180-Day Nasdaq Extension to Regain Bid Price Compliance

Cosmos Health secures additional 180-day Nasdaq extension to regain compliance.

Victoria’s Secret & Co. Shareholders Decisively Re-Elect All Nine Company Director Nominees

Outcome reflects strong shareholder support for full Board, Company’s Path to Potential strategy and continued momentum under CEO Hillary Super

Prairie Operating Co. Reaffirms $475 Million Credit Facility and Advances Series F Preferred Refinancing Initiatives

HOUSTON, TX, June 11, 2026 (GLOBE NEWSWIRE) -- Prairie Operating Co. (Nasdaq: PROP) (the “Company” or “Prairie”), an independent energy company engaged in the development and acquisition of oil and natural gas resources in the Denver-Julesburg (DJ) Basin – today announced a series of actions that further strengthen the Company’s financial position, enhance liquidity, and continue to reduce potential shareholder dilution associated with the Company’s Series F Convertible Preferred Stock.

FPX Nickel Provides Environmental Assessment Progress Update – Confirmation of Federal Assessment for Baptiste and Coordinated Federal and Provincial Review

VANCOUVER, BC, June 11, 2026 /CNW/ - FPX Nickel Corp. (TSXV: FPX) (OTCQX: FPOCF) ("FPX" or the "Company") acknowledges that, as previously anticipated, the Impact Assessment...

Compass Diversified Announces CEO Succession Plan

Co-Founder and Chief Executive Officer Elias Sabo to Retire at Year End

Haleon Announces ~₹2000 Crore Total Investment to Set Up its First Manufacturing Facility in India

Greenfield facility in Madhya Pradesh to support 'Make in India' vision and strengthen Haleon's commitment to delivering better everyday healthStrategic oral health-focused site designed...

Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026

ZUG, Switzerland, June 11, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology and ophthalmology, today announced an upcoming presentation at Clinical Trials at the Summit 2026, taking place on June 12-13, 2026, in Las Vegas, Nevada.

Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026

ZUG, Switzerland, June 11, 2026 – Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology and ophthalmology, today announced an upcoming presentation at Clinical Trials at the Summit 2026, taking place on June 12-13, 2026, in Las Vegas, Nevada.

Hope and inspiration: China-Greece cultural dialogue’s contemporary relevance

BEIJING, June 11, 2026 /PRNewswire/ -- A report from People's Daily: The second World Conference of Classics convened on June 9 and 10 in Athens,...

Rockwell Automation Announces Zinkteknik Selects Plex Smart Manufacturing Platform to Standardize Operations and Support Global Growth

Automotive tier 2 zinc die-casting manufacturer adopts cloud-based MES, QMS, EDI and analytics to provide real-time visibility, traceability and quality across a new greenfield...

Vivoryon Therapeutics N.V. Reports Q1 2026 Financial Results and Provides Business Update

Vivoryon Therapeutics N.V. Reports Q1 2026 Financial Results
and Provides Business Update

Manulife Asia Care Survey 2026: Independence as Asia’s New Legacy

From living longer to living free, people across Asia prioritize health and financial self-sufficiency to pursue independence and avoid burdening loved onesHONG KONG, June...

- A word from our sponsors -

spot_img
HomeTagsProgress